All News

ViewPoints: Sarepta benefits from battles already won with Amondys 45

Ref: ViewPoints Desk

Tags: ViewPoints Sarepta Therapeutics Pfizer Solid Biosciences Duchenne Muscular Dystrophy FDA Marketing & Sales Medical Affairs Regulatory Affairs AMONDYS 45 Exondys 51 Vyondys 53

Recommendations for Evrysdi, Orladeyo lead decisions from CHMP's February meeting

Ref: EMA

Tags: Top Story EMA Regulatory Affairs

Panama to buy 2 million more doses of Pfizer vaccine

Ref: National Post

Tags: NewsPoints Pfizer COVID-19 Immunisation Marketing & Sales

Scientists Reveal Details of Antibodies that Work Against Zika Virus

Ref: Biophysical Society

Tags: Press Release Biophysical Society Zika Clinical Research (R&D)

Johnson & Johnson Announces U.S. CDC Advisory Committee Recommends First Single-Shot COVID-19 Vaccine for Adults 18 and Older in U.S.

Ref: Johnson &, Johnson

Tags: Press Release J&J COVID-19 Immunisation CDC Regulatory Affairs Medical Affairs Marketing & Sales

J&J's COVID-19 shot gets CDC panel backing; vaccine near shipping

Ref: Yahoo Finance

Tags: NewsPoints J&J United States COVID-19 Immunisation CDC Marketing & Sales Medical Affairs Regulatory Affairs

China's CanSino says first vaccines packaged in Mexico will be ready in March

Ref: This is Money

Tags: NewsPoints CanSino Biologics COVID-19 Immunisation Corporate Affairs Marketing & Sales

S.Africa signs deal with J&J for 11 mln vaccine doses, Ramaphosa says

Ref: National Post

Tags: NewsPoints J&J COVID-19 Immunisation Marketing & Sales

Pfizer vaccine may be less effective in people with obesity, says study

Ref: The Guardian

Tags: NewsPoints BioNTech Pfizer COVID-19 Immunisation Obesity Clinical Research (R&D) Medical Affairs

France authorises first synthetic antibody treatment for Covid-19

Ref: RFI

Tags: NewsPoints Celltrion J&J Lilly Regeneron COVID-19 EMA Marketing & Sales Regulatory Affairs bamlanivimab casirivimab imdevimab